ZYMOGENETICS INC (ZGEN) Stock Quote

Detailed Quote for ZYMOGENETICS INC (ZGEN) 
$ N/A N/A (N/A) Volume: N/A
Today 5d 1m 3m 1y more
Last Price
N/A
Change $
N/A
Change %
N/A
Tick
N/A
Bid
N/A
Bid Size
0
Ask
N/A
Ask Size
0
Open
N/A
High
N/A
Low
N/A
Prev Close
N/A
Last Trade
N/A
Volume
52 Wk Hi
9.79
52 Wk Low
3.70
Market Cap
N/A
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
85,904,484
EPS (TTM)
-0.04
PE Ratio
N/A
Exchange
NSD
News and Media for ZYMOGENETICS INC  (ZGEN) 
Sector News | Topic News
News for ZGEN
Fri, Nov 06, 2009
2:38 PM CEL-SCI's H1N1 Clinical Study News Seen as Credibility Booster - Accesswire
Mon, Oct 05, 2009
8:03 AM Oncothyreon announces appointment of Douglas E. Williams, Ph.D., to board of directors - Canada Newswire
More News for ZGEN >>

Tags for ZYMOGENETICS INC

Research stocks or mutual funds related to ZYMOGENETICS INC by keywords or tags. Find companies that have a similar focus to ZGEN. The keywords below have been associated to ZGEN by either user submission or electronic means.

clinical trials database clinical trial enrollment stock investments online stock quote clinical trial research clinical cost pharmaceuticals clinical trials live stock quote interferon receptor stock market ticker stock investment Biological Products clinical trials uk stock market chart stock quote best stocks corporate governance practices novartis pharmaceuticals corporate governance issues stock quote chart bp stock quotes at&t stock quote board of directors role nyse stock quote stock market quotes phase 3 clinical trials clinical trials manager corporate governance disclosure board of directors governance stock quote rss stock news stock split stock quote web service patient recruitment clinical trials role of the board of directors physician clinical trials Drugs current stock quote stock charts stock ticker sirius stock quote stocks medical device clinical trial board of directors compensation nasdaq stock quotes historical stock quotes board of directors responsibility stock quote msft financial audit live stock prices